🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...
Status
Completed
Location
Radboud University
Start Date
2021-09-20
Trial ID
NCT05082688
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
The primary objective of this study is to demonstrate the immunologic nonin...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01091246
Treatments Being Tested
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
The aim of the study was to assess the immunogenicity and safety of Fluzone...
Status
Completed
Location
Sanofi Pasteur Investigational Site 002
Start Date
2015-06-17
Trial ID
NCT03546192
Treatments Being Tested